|12 Months Ended|
Dec. 31, 2020
NOTE 7 – STOCKHOLDERS’ EQUITY
2019 Public Offering of Common Stock and “Pre-Funded” Warrants
On December 24, 2019, we closed an underwritten public offering of 9,017,055 shares of common stock at a purchase price of $2.4999 per pre-funded warrant, which equals the public offering price per share of the common stock less the $0.0001 per share exercise price of each pre-funded warrant. The gross proceeds to the Company were approximately $103.5 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company. shares of common stock at a public offering price of $ per share. In addition, as part of the offering, we sold “pre-funded” warrants to purchase up to an aggregate of
In October 2020, all of the 9,017,055 “pre-funded” warrants were exercised and converted into shares of common stock. We received a negligible amount of cash from the exercise of these pre-funded warrants during 2020.
“Non-pre-funded” warrants to purchase a total of 70,000 shares of common stock were outstanding as of December 31, 2019. These “non-pre-funded” warrants expired unexercised during 2020. We did not receive cash from the exercise of “non-pre-funded” warrants during 2020 or 2019.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef